Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening
about
sameAs
Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic FibrosisIvacaftor for patients with cystic fibrosisBronchoscopy-guided antimicrobial therapy for cystic fibrosisVitamin K supplementation for cystic fibrosisTopical nasal steroids for treating nasal polyposis in people with cystic fibrosisPotentiators (specific therapies for class III and IV mutations) for cystic fibrosisPsychological interventions for individuals with cystic fibrosis and their familiesVitamin K supplementation for cystic fibrosisTopical nasal steroids for treating nasal polyposis in people with cystic fibrosisAntibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbationMutation-specific therapies that potentiate cystic fibrosis transmembrane conductance regulator (CFTR) function in cystic fibrosisTopical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung diseaseCorrectors (specific therapies for class II CFTR mutations) for cystic fibrosisBronchoscopy-guided antimicrobial therapy for cystic fibrosisTopical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung diseaseTopical nasal steroids for treating nasal polyposis in people with cystic fibrosisAntibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbationVitamin K supplementation for cystic fibrosisBronchoscopy-guided antimicrobial therapy for cystic fibrosisVitamin K supplementation for cystic fibrosisTopical nasal steroids for treating nasal polyposis in people with cystic fibrosisSelf-management education for cystic fibrosisPsychological interventions for people with cystic fibrosis and their familiesTopical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung diseaseTopical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung diseaseDevelopments in FINDbase worldwide database for clinically relevant genomic variation allele frequenciesChloride channels as drug targets.FINDbase: a worldwide database for genetic variation allele frequencies updatedDrug discovery: lessons from evolutionCFTR mutation analysis and haplotype associations in CF patientsFine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophreniaRescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Evaluating candidate agents of selective pressure for cystic fibrosisComputational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methodsTopical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung diseasePopulation Genomics and the Statistical Values of Race: An Interdisciplinary Perspective on the Biological Classification of Human Populations and Implications for Clinical Genetic Epidemiological ResearchEpidemiology and genetics of cystic fibrosis in Asia: In preparation for the next-generation treatmentsCystic fibrosis and lactase persistence: a possible correlationMolecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosisMechanisms for quality control of misfolded transmembrane proteins
P2860
Q21129282-FD8B33E4-D059-468D-8A7C-BAD8F750CB67Q22305938-DB97DD57-A6FF-4914-9A6B-184EC9B43AEFQ24186413-52049882-79CC-48C5-A929-02297B6FC0F6Q24186592-1FA4EFDF-49CA-447C-A078-1E35FA5701F0Q24187053-14B1B707-8B6F-457A-8644-D3059DCFF0F7Q24187139-581F0E03-FF02-4E92-AFA1-29722FCBE409Q24193892-A69E77FF-CB56-449B-8ABC-EAC43BB0372EQ24197634-EF3A5922-0AD4-4C7A-BC27-B8D437D7C1EFQ24197927-55993C4A-C6F6-4665-B2EF-BEE022950F59Q24198135-B1207CBE-B636-42F1-A6DE-4ABECD56CC26Q24198183-6C7FA004-4395-4ACD-8432-DDD09ED3C66FQ24198270-F734A399-6250-4147-BB80-1F73EE4301A9Q24200710-1EC56C56-033B-4981-982A-9198FAE8830BQ24201620-C1A676B1-7F7B-4080-B732-0D85179636C2Q24202357-36468B11-8733-4C17-B9B2-E64AEC4290E1Q24234445-94EC1B80-0EEE-4AE6-9BF2-4B04EF8B56ABQ24234854-596DBA1E-0756-41CD-B389-4E808B8C7AC9Q24234866-34036E84-04F7-43ED-97CC-CDAFD3B24E84Q24234964-78BE405A-7B5F-494B-AA71-37D2719D0399Q24236156-9E885C14-FD3C-4316-BE15-C58FD93F388BQ24241414-A057EC69-E4BE-4599-A738-0B54863F792DQ24242757-3663D51B-A437-4D4B-A170-2729809F9A1DQ24242795-C3D6D11C-7D1E-4780-93E5-B706A284F2E6Q24245035-225E1965-3587-44F6-93AE-3FFB21C337EDQ24245040-330BE7E2-E2C1-4D4B-A531-4D2CC363D289Q24567762-4DC60F8E-7932-4BCB-B417-6D4290F2114BQ24601830-8F0E60FF-1364-4F8A-BD60-ED3E15157696Q24610176-45C6C3AD-A9C0-4F93-8C37-B2D3BEABB765Q24610693-1FDA91E3-D7A3-47A3-B1FF-8356EFD1B820Q24631237-89722A83-5589-4CD8-9E2F-E90B3F416448Q24643955-160A4A0E-A871-4774-80AF-4F999C5E2FE0Q24644303-74D650DA-0F50-404C-BBD9-E4612EFB5E49Q24654240-4F53FD2C-D6D5-46EE-B071-AED80F509436Q25255759-D4DFC958-7D1E-4CE6-A55E-00B1D2620756Q26471459-127D5FE8-E224-46C7-B48C-4B7652FB433DQ26765823-9045A17B-9042-4058-9C06-12A8419C8E93Q26781980-28A848F9-4AB3-488D-ABF8-831FD6C7B545Q26810017-E40A54D0-4F05-449C-992A-5E343FE4DAB6Q26826845-81A9DA66-DB87-4BC3-B046-EA8DC5FCF753Q26830475-F8C7B877-0A80-4E1B-A8F2-3A8A87498BCF
P2860
Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening
description
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Juni 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: June 2002)
@en
vedecký článok (publikovaný 2002-06)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-06)
@nl
наукова стаття, опублікована в червні 2002
@uk
مقالة علمية (نشرت في يونيو 2002)
@ar
name
Cystic fibrosis: a worldwide a ...... a and application to screening
@ast
Cystic fibrosis: a worldwide a ...... a and application to screening
@en
Cystic fibrosis: a worldwide a ...... a and application to screening
@nl
type
label
Cystic fibrosis: a worldwide a ...... a and application to screening
@ast
Cystic fibrosis: a worldwide a ...... a and application to screening
@en
Cystic fibrosis: a worldwide a ...... a and application to screening
@nl
prefLabel
Cystic fibrosis: a worldwide a ...... a and application to screening
@ast
Cystic fibrosis: a worldwide a ...... a and application to screening
@en
Cystic fibrosis: a worldwide a ...... a and application to screening
@nl
P2093
P3181
P356
P1433
P1476
Cystic fibrosis: a worldwide a ...... a and application to screening
@en
P2093
Jason P Fine
Joseph L Bobadilla
Milan Macek
Philip M Farrell
P304
P3181
P356
10.1002/HUMU.10041
P407
P577
2002-06-01T00:00:00Z